Leerink Partnrs Issues Optimistic Estimate for PTCT Earnings
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Leerink Partnrs raised their Q1 2025 EPS estimates for PTC Therapeutics in a report released on Tuesday, May 6th. Leerink Partnrs analyst J. Schwartz now forecasts that the biopharmaceutical company will post earnings of $10.04 per share for the quarter, up from their previous forecast of ($1.47). […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Leerink Partnrs raised their Q1 2025 EPS estimates for PTC Therapeutics in a report released on Tuesday, May 6th. Leerink Partnrs analyst J. Schwartz now forecasts that the biopharmaceutical company will post earnings of $10.04 per share for the quarter, up from their previous forecast of ($1.47). […]
